Lanean...
Targeted Gold Nanocluster-enhanced Radiotherapy of Prostate Cancer
Prostate-Specific Membrane Antigen (PSMA) targeted radiosensitizers are developed for prostate cancer radiotherapy based on gold nanoclusters and a high-affinnity targeting peptide, PSMA-1 (CY-PSMA-1-Au(25)NCs). The CY-PSMA-1-Au(25)NCs can achieve rapidly and selectively uptake by prostate cancer in...
Gorde:
| Argitaratua izan da: | Small |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707872/ https://ncbi.nlm.nih.gov/pubmed/31265213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201900968 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|